Skip to main content

Table 3 MS charges a by presence of selected disease sequelae in 2011

From: Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data

Condition Diagnosis codeb N Prevalence Mean [SD] charges ($) PValue
Abnormality of gait 781.2 1,196 7.5 48,361 [55,472] <0.001
Ataxia 781.3 347 2.2 48,605 [63,100] <0.001
Burning, numbness, tingling sensations 782.0 1,566 9.8 33,648 [45,273] <0.001
Convulsionsc 780.3 0 0.0 --- ---
Depressiond 296.2, 296.3, 300.4, 311; DRG = 881 1,255 7.9 42,831 [51,693] <0.001
Fecal incontinence 787.6 0 0.0 --- ---
Fibromyalgia/myalgia and myositis 729.1 399 2.5 38,319 [63,441] <0.001
Malaise and fatiguec 780.7 2,235 14.1 39,948 [48,435] <0.001
Optic neuritis 341.0 38 0.2 82,134 [98,886] 0.001
Spasms 781.0 412 2.6 48,337 [52,475] <0.001
Trigeminal neuralgia 350.1 150 0.9 38,165 [46,506] 0.002
Urinary incontinencec 788.3 339 2.1 47,885 [49,226] <0.001
Voice disturbancec 784.4, 784.5 23 0.1 44,973 [57,858] 0.140
  1. aSum of the charges for (1) medical claims with an MS diagnosis (ICD-9-CM = 340.xx in any diagnosis field or a DRG code for MS and cerebellar ataxia [DRG = 058, 059, or 060]) plus (2) medical or pharmacy claims indicating a DMD (Table 1).
  2. bICD-9-CM coding except where otherwise specified.
  3. cIdentified by Prescott et al. using a combination of ICD-9-CM codes and ETG coding [10].
  4. dIdentified by Prescott et al. using only ETG coding [10].
  5. DMD = disease-modifying drug; DRG = Diagnosis-Related Group; ETG = Episode Treatment Group; ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; MS = multiple sclerosis; SD = standard deviation.
\